Tomasz Tabernacki
Overview
Explore the profile of Tomasz Tabernacki including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
76
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Loria M, Tabernacki T, Fraiman E, Perez J, Zeki J, Palozzi J, et al.
Commun Med (Lond)
. 2024 Dec;
4(1):283.
PMID: 39741205
Background: The objective of this study is to evaluate the risk of being diagnosed with an eating disorder among transgender and gender-diverse (TGD) individuals, specifically examining how this risk differs...
2.
Tabernacki T, Loria M, Rhodes S, Pope R, Gupta S, Banik S, et al.
Int J Transgend Health
. 2024 Oct;
25(4):896-910.
PMID: 39465080
Background: Transgender individuals frequently undergo gender-affirming hormone therapy (GAHT) during their gender transition which plays a vital role in gender identity affirmation. Cholelithiasis, a common condition affecting 10-15% of the...
3.
Tabernacki T, Gilbert D, Rhodes S, Scarberry K, Pope R, McNamara M, et al.
Eur J Pain
. 2024 Sep;
29(2):e4725.
PMID: 39305003
Background: Chronic pain, affecting approximately 20% of the global population, is the leading cause of disability worldwide. Transgender individuals are disproportionately exposed to chronic pain risk factors compared with the...
4.
Tabernacki T, Wang L, Kaelber D, Xu R, Berger N
Cancers (Basel)
. 2024 Jul;
16(13).
PMID: 39001440
Lung cancer (LC) is the second most common cancer and the leading cause of cancer deaths in the U.S. Insulin therapy, a key treatment for managing Type 2 Diabetes Mellitus...
5.
Loria M, Tabernacki T, Gilbert D, Maravillas M, McNamara M, Gupta S, et al.
Prostate Cancer Prostatic Dis
. 2024 Jul;
28(1):236-237.
PMID: 38969790
No abstract available.
6.
Gilbert D, Gautam A, Tabernacki T, Rhodes S, McNamara M, Banik S, et al.
Urology
. 2024 Apr;
188:150-155.
PMID: 38657871
Objective: To describe urinary tract infection (UTI) risk 3-month postvaginoplasty (VP) in transgender women (TW) compared to cis women (CW). Methods: Using TriNetX (TriNetX, Inc, Cambridge, MA), we built cohorts...
7.
Loria M, Gilbert D, Tabernacki T, Maravillas M, McNamara M, Gupta S, et al.
Prostate Cancer Prostatic Dis
. 2024 Feb;
28(1):232-234.
PMID: 38326392
The risk of prostate cancer among transgender women undergoing medical and surgical gender-affirming interventions remains unclear, though up to a fivefold decreased risk has been reported in comparison to cisgender...
8.
Gomez S, Tabernacki T, Kobyra J, Roberts P, Chiappinelli K
Semin Cancer Biol
. 2019 Dec;
65:99-113.
PMID: 31877341
Cancer undergoes "immune editing" to evade destruction by cells of the host immune system including natural killer (NK) cells and cytotoxic T lymphocytes (CTLs). Current adoptive cellular immune therapies include...